Saint John’s Cancer Institute
Saint John's Cancer Institute is a non-profit cancer research and treatment center in Santa Monica, California, operating within the Providence Health system and serving cancer patients across 12 specialty Centers of Excellence with integrated translational research and fellowship training programs.
- Company typePrivate
- Founded2021
- HeadquartersSanta Monica, United States
- Headcount251–500
- GTM typeB2C
- OfferingServices
What Saint John’s Cancer Institute does
Saint John's Cancer Institute (SJCI) is a non-profit cancer research and treatment organization headquartered in Santa Monica, California, operating as a component of the Providence Health system and affiliated with Providence Saint John's Health Center. The institute was renamed from John Wayne Cancer Institute in 2021, building on the legacy of Dr. Donald L. Morton, who pioneered the Sentinel Lymph Node Biopsy technique that became the worldwide standard of care for melanoma and breast cancer. SJCI operates 12 Centers of Excellence spanning brain, breast, endocrine, gastrointestinal, gynecologic, head and neck, melanoma, thoracic, urologic, radiation, and translational research disciplines, supported by a faculty of 34 scientists and clinicians and five fellowship programs.
SJCI's core offering combines advanced clinical treatment with translational laboratory research. Clinical capabilities include Histotripsy (Edison System by HistoSonics) for liver tumors, Pulse Electric Field Ablation for early-stage lung tumors (first in Los Angeles County), Intraoperative Radiation Therapy (IORT) for breast cancer, robotic-assisted surgery (Da Vinci Xi), and 3D-guided robotic bronchoscopy for lung nodule biopsy down to 6–7 mm. The Translational Research Departments focus on liquid biopsies, circulating tumor cells, epigenetic mechanisms, pharmacogenomics, and immunogenomic prediction of therapy response, with research output of 74 peer-reviewed studies published in 2025.
The institute is funded through a mix of clinical care services at Providence Saint John's Health Center, research grants from foundations including the CORI Foundation, Adelson Medical Research Foundation, and The Riordan Foundation, and philanthropic donations channeled through the Saint John's Health Center Foundation. The customer base is individual cancer patients accessed via physician referrals, self-referrals, and Providence network referrals across Southern California, with international research collaborations extending reach to partners such as Keio University in Tokyo.
Saint John’s Cancer Institute firmographics
Firmographics- Name
- Saint John’s Cancer Institute
- Legal name
- Saint John's Cancer Institute
- Website
- https://saintjohnscancer.org
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Saint John's Cancer Institute is a non-profit cancer research and treatment center in Santa Monica, California, operating within the Providence Health system and serving cancer patients across 12 specialty Centers of Excellence with integrated translational research and fellowship training programs.
- Ownership category
- akta.pro rank
Saint John’s Cancer Institute industry classification
Industry- Product category
- Oncology Treatment Services
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), General Medical and Surgical Hospitals (62211), Offices of Physicians (except Mental Health Specialists) (621111)
- SIC
- Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)
- akta.pro secondary industries
- Oncology & Cancer Specialty Hospitals (HLAFAHAC), Medical Oncology (HLAKAFAB), Digestive Oncology (GI Cancer Care) (HLAKAEAF), Urologic Oncology (HLAKAOAB), Thoracic (Lung) Oncology (HLAKAFAL)
Keywords
Where Saint John’s Cancer Institute is headquartered
LocationHeadquarters
- HQ city
- Santa Monica
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Saint John’s Cancer Institute business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Clinical Care Services: Revenue generated from cancer treatment, diagnostic services, and clinical procedures at Providence Saint John's Health Center.
- Research Grants and Foundation Funding: Funding from organizations such as CORI Foundation, Adelson Medical Research Foundation, and Saint John's Health Center Foundation to support research programs and innovation.
- Donations and Philanthropy: Tax-deductible donations to support life-saving cancer research, fellowships, and equipment such as the histotripsy system supported by The Riordan Foundation.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Other | Standard clinical care pricing varies by procedure and insurance coverage |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels9 records
Saint John’s Cancer Institute product offering
Product offeringCore offering
Saint John's Cancer Institute is a non-profit cancer research and treatment center that delivers multidisciplinary oncology care through 12 Centers of Excellence spanning breast, lung, gastrointestinal, urologic, gynecologic, melanoma, neurological, endocrine, and head & neck cancers. It operates active clinical trials across multiple cancer types, five fellowship training programs, and translational research programs that move laboratory discoveries into clinical practice. The institute also offers advanced treatment technologies including histotripsy, PEF ablation, robotic bronchoscopy, IORT, and Da Vinci Xi robotic surgery.
Product overview
Saint John's Cancer Institute is a renowned cancer research and treatment center offering a comprehensive portfolio of cancer care services organized through 12 Centers of Excellence, active Clinical Trials programs, and five Fellowship training programs. The Institute provides advanced treatment technologies including Histotripsy (Edison System by HistoSonics) for liver cancer, Intraoperative Radiation Therapy (IORT) for breast cancer, Pulse Electric Field (PEF) Ablation for lung tumors (first in Los Angeles County), robotic surgery (Da Vinci Xi), and 3D-guided robotic bronchoscopy for lung diagnostics. Supporting services include Cancer Support Services, Translational Research Departments focused on liquid biopsies and molecular medicine, and patient resources such as the Banchik Family Library. The institute conducts clinical trials across multiple cancer types and provides fellowship training in surgical oncology, breast oncology, neurosurgery, urology, and translational molecular medicine.
Differentiator
Problem solved
Functional benefit
Brands
- Margie Petersen Breast Center: A comprehensive breast center providing multidisciplinary team approach for breast health conditions
- Vasek Polak Radiation Oncology Department
- Translational and Precision Medicine Laboratory
Products and services
- Centers of Excellence Multidisciplinary cancer care centers covering 12 specialty areas: Brain Tumors & Neuroscience, Breast Surgery and Oncology, Endocrine Tumors, Gastrointestinal and Hepatobiliary Tumors, Gynecologic Oncology, Head and Neck Oncology, Melanoma/Skin/Soft Tissue, Pathology, Pulmonology & Thoracic Oncology, Urology and Urologic Oncology, Radiation Oncology, and Translational Research Departments. Each provides coordinated surgical, medical, and radiation oncology care.
- Clinical Trials Program
- Fellowship Programs
- Histotripsy for Liver Cancer Non-invasive outpatient procedure using the Edison System by HistoSonics — high-intensity focused ultrasound waves create cavitation bubbles that mechanically disrupt and destroy liver tumor cells in 10-50 minutes per tumor with no side effects.
- Intraoperative Radiation Therapy (IORT)
- Pulse Electric Field (PEF) Ablation for Lung Tumors
Quantifiable outcome
- Low-dose CT screening reduces lung cancer mortality by 20% in high-risk patients
- +2 more outcomes
Companies that use Saint John’s Cancer Institute
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
Saint John’s Cancer Institute technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Saint John’s Cancer Institute partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered key and collaborative.
- Keio University (Tokyo, Japan)keyInternational research collaboration with Dr. Kodai Abe examining the role of ILF2 gene in intrahepatic cholangiocarcinoma, contributing to biomarker discovery and potential therapeutic targets.
- American Cancer SocietykeyPartnership to elevate lung cancer screening through community outreach. NFL grant through ACS supporting Saint John's lung cancer screening initiatives and early detection programs.
- Pacific Neuroscience InstitutecollaborativeCollaboration with Pacific Neuroscience Institute for head and neck oncology, developing multidisciplinary, team-based treatment plans for patients.
Scale indicators6 records
Recent moves7 records
Expansion highlights5 records
Saint John’s Cancer Institute competitors and assessment
Company assessmentDirect peers
- City of Hope: NCI-designated comprehensive cancer center based in Duarte, CA with a major LA presence; offers similar multidisciplinary oncology, clinical trials, and translational research and competes for patients across Southern California.
- USC Norris Comprehensive Cancer Center: NCI-designated comprehensive cancer center at Keck Medicine of USC in Los Angeles providing multidisciplinary oncology care, translational research, and fellowship training comparable to SJCI's offerings.
- Cedars-Sinai Cancer: Large Los Angeles academic cancer program within Cedars-Sinai Medical Center offering surgical, medical, and radiation oncology with active research and clinical trials; directly comparable in scope and geography to SJCI.
- UCLA Health (Jonsson Comprehensive Cancer Center): NCI-designated comprehensive cancer center in Los Angeles offering multidisciplinary oncology care, clinical trials, and translational research across the same cancer specialties as SJCI; directly competes for patients, faculty, and grant funding in the LA market.
Others
- HistoSonics: Maker of the Edison histotripsy system used by SJCI for liver tumor treatment; ecosystem/technology partner relevant to SJCI's adoption of next-generation non-invasive oncology devices.
- Providence Health (system parent): Large non-profit Catholic health system that operates SJCI as a component; provides infrastructure, payer contracts, and referral pathways that define SJCI's operating context and growth ceiling.
Broad incumbents
- MD Anderson Cancer Center: Leading NCI-designated comprehensive cancer center in Houston with deep subspecialty oncology programs, clinical trials, and translational research; serves as a broad incumbent peer in cancer specialty care and academic oncology.
- Memorial Sloan Kettering Cancer Center: Largest and oldest US specialty cancer center, providing multidisciplinary oncology care, translational research, and fellowship training; sets the bar for specialty oncology brands and academic reputation comparable to SJCI's SNLB legacy.
- Dana-Farber Cancer Institute: Harvard-affiliated specialty cancer center in Boston with strong translational research, fellowship training, and multidisciplinary care; comparable to SJCI in combining research leadership with specialty oncology delivery.
Regional players
- Stanford Cancer Institute: NCI-designated cancer center at Stanford Medicine offering comprehensive oncology, translational research, and fellowship programs analogous to SJCI; competes for high-acuity California patients but is based in Northern California.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights7 records
Customer concentration
Saint John’s Cancer Institute social profiles
Digital presenceSaint John’s Cancer Institute financial estimates
Financial estimateRevenue estimate
Valuation estimate
Saint John’s Cancer Institute leadership team
Management profileNumber of profiles
Profiles10 records
Saint John’s Cancer Institute funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Saint John’s Cancer Institute M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Saint John’s Cancer Institute
What does Saint John’s Cancer Institute do?
Saint John's Cancer Institute is a non-profit cancer research and treatment center that delivers multidisciplinary oncology care through 12 Centers of Excellence spanning breast, lung, gastrointestinal, urologic, gynecologic, melanoma, neurological, endocrine, and head & neck cancers. It operates active clinical trials across multiple cancer types, five fellowship training programs, and translational research programs that move laboratory discoveries into clinical practice. The institute also offers advanced treatment technologies including histotripsy, PEF ablation, robotic bronchoscopy, IORT, and Da Vinci Xi robotic surgery.
Is Saint John’s Cancer Institute a public or private company?
Saint John’s Cancer Institute is a private company. It is classified as corporate owned and is currently operating.
When was Saint John’s Cancer Institute founded?
Saint John’s Cancer Institute was founded in 2021. It employs 251 to 500 people.
Where is Saint John’s Cancer Institute based?
Saint John’s Cancer Institute is headquartered in Santa Monica, United States, in the North America region.
How does Saint John’s Cancer Institute make money?
Three revenue lines are on record. Clinical Care Services are the primary driver. The others are research Grants and Foundation Funding and donations and Philanthropy.
Who are Saint John’s Cancer Institute's main competitors?
Direct peers on record are City of Hope, USC Norris Comprehensive Cancer Center, Cedars-Sinai Cancer and UCLA Health (Jonsson Comprehensive Cancer Center). Others are HistoSonics and Providence Health (system parent). Broad incumbents are MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute. Stanford Cancer Institute is listed as a regional player.
Does Saint John’s Cancer Institute have an API?
No public API is recorded for Saint John’s Cancer Institute.
What industry is Saint John’s Cancer Institute in?
Saint John’s Cancer Institute's product category is Oncology Treatment Services. Its primary akta.pro industry code is HLAFAAAM, Hospital-Integrated Cancer Centers (Acute Oncology Programs), with a secondary code of HLAFAHAC, Oncology & Cancer Specialty Hospitals. Its NAICS code is 62231 and its SIC code is 8062.